Corteva, Inc.

DB:2X0 Stock Report

Market Cap: €41.1b

Corteva Valuation

Is 2X0 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 2X0 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 2X0 (€60.5) is trading below our estimate of fair value (€65.94)

Significantly Below Fair Value: 2X0 is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 2X0?

Key metric: As 2X0 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 2X0. This is calculated by dividing 2X0's market cap by their current earnings.
What is 2X0's PE Ratio?
PE Ratio64.9x
EarningsUS$670.00m
Market CapUS$43.47b

Price to Earnings Ratio vs Peers

How does 2X0's PE Ratio compare to its peers?

The above table shows the PE ratio for 2X0 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average50.8x
SDF K+S
78.9x61.1%€2.0b
BAS BASF
75.7x34.2%€37.6b
SY1 Symrise
37.3x13.4%€14.6b
HEI Heidelberg Materials
11.3x7.8%€21.0b
2X0 Corteva
64.9x26.8%€43.5b

Price-To-Earnings vs Peers: 2X0 is expensive based on its Price-To-Earnings Ratio (64.9x) compared to the peer average (50.8x).

Price to Earnings Ratio vs Industry

How does 2X0's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
2X0 64.9xIndustry Avg. 17.3xNo. of Companies13PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 2X0 is expensive based on its Price-To-Earnings Ratio (64.9x) compared to the European Chemicals industry average (17.2x).

Price to Earnings Ratio vs Fair Ratio

What is 2X0's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

2X0 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio64.9x
Fair PE Ratio29.7x

Price-To-Earnings vs Fair Ratio: 2X0 is expensive based on its Price-To-Earnings Ratio (64.9x) compared to the estimated Fair Price-To-Earnings Ratio (29.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 2X0 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€60.50
€62.66
+3.6%
6.9%€67.73€54.38n/a22
Nov ’25€55.86
€59.21
+6.0%
7.6%€64.72€50.85n/a22
Oct ’25€51.97
€56.80
+9.3%
7.3%€62.98€49.48n/a22
Sep ’25€50.30
€56.80
+12.9%
7.3%€62.98€49.48n/a22
Aug ’25€49.70
€58.64
+18.0%
6.5%€64.87€51.90n/a21
Jul ’25€48.51
€58.90
+21.4%
6.8%€65.20€50.30n/a21
Jun ’25€49.97
€58.67
+17.4%
6.8%€64.53€49.78n/a20
May ’25€50.90
€58.46
+14.9%
7.5%€65.58€49.65n/a23
Apr ’25€52.80
€57.20
+8.3%
7.7%€64.89€49.13n/a23
Mar ’25€48.05
€57.03
+18.7%
7.4%€64.76€49.04n/a24
Feb ’25€50.10
€54.44
+8.7%
9.9%€64.40€46.00n/a24
Jan ’25€42.30
€53.70
+27.0%
9.6%€65.36€45.52n/a24
Dec ’24€40.80
€53.70
+31.6%
9.6%€65.36€45.52n/a24
Nov ’24€44.65
€61.88
+38.6%
10.7%€77.24€49.92€55.8623
Oct ’24€46.60
€65.04
+39.6%
8.2%€77.42€53.82€51.9722
Sep ’24€45.85
€63.46
+38.4%
8.3%€75.40€52.41€50.3022
Aug ’24€50.40
€63.13
+25.3%
8.3%€74.13€51.53€49.7023
Jul ’24€51.40
€65.50
+27.4%
7.2%€75.13€55.89€48.5123
Jun ’24€48.35
€66.89
+38.3%
7.8%€80.86€56.69€49.9722
May ’24€53.20
€66.50
+25.0%
8.1%€79.37€54.74€50.9021
Apr ’24€53.60
€68.53
+27.9%
7.8%€81.58€56.26€52.8021
Mar ’24€57.34
€68.03
+18.6%
8.1%€81.21€56.00€48.0521
Feb ’24€57.42
€67.20
+17.0%
7.7%€79.95€56.98€50.1021
Jan ’24€57.04
€68.29
+19.7%
7.8%€82.09€58.50€42.3020
Dec ’23€65.20
€68.95
+5.7%
8.0%€82.65€58.90€40.8020
Nov ’23€66.44
€71.65
+7.8%
6.8%€81.77€62.35€44.6520

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Compañía de Minas BuenaventuraA

US$3.0b

Engages in the exploration, development, construction, and operation of mineral processing business.

MBU

US$11.30

7D

-3.4%

1Y

32.9%

Mitsubishi Chemical Group

JP¥1.1t

Provides performance products, chemicals, industrial gases, health care products, and other products in Japan and internationally.

M3C

JP¥5.20

7D

3.6%

1Y

-9.4%

Cabka

€62.8m

Manufactures and sells pallets and large containers made from recycled plastic in Europe, North America, and internationally.

7GW

€2.48

7D

0%

1Y

-59.9%